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Abstract
In the last years, genetic polymorphisms have raised interest for their role on the 
environmental and occupational exposures. They not only are studied at population 
level to identify genetic diversity among ethnicities but have been recognized also as 
biomarkers of genetic susceptibility in many fields including medicine, health pre-
vention, epidemiology and pharmacology. In the occupational context, the investi-
gation of gene polymorphisms is part of the biomonitoring of workers exposed to 
occupational toxicants and carcinogens. However the majority of workers coming 
from foreign countries may be not familiar with the standard procedures used in the 
biomonitoring campaigns, which include human biosample harvesting for genetic, 
metabolic and genotoxic studies. Here we describe the importance of gene polymor-
phism association with dose and genotoxicity biomarkers and propose a statistical 
model predicting ethnic-specific susceptibilities based on the genotypes available in 
public databases when the access to blood genotyping test is not always feasible.
Keywords: biological monitoring, biomarker, biosample, environmental, ethnicity, 
gene polymorphism, occupational, susceptibility risk, worker
1. Introduction
The genetic variability is something common to all the living organisms and 
has important implications for the evolution and conservation of every species. It 
is widely known the differences in the phenotype among individuals are strictly 
dependent on two factors: the genotype, which is inherited from our ancestors, and 
the surrounding environmental exposure that contributes to shape the phenotype. 
The interindividual and intraindividual genetic differences make humans special 
and unique determining for each a single identity. Although genetics influences 
our physical appearance, behaviour, thoughts and habits, we recognize also the 
environment plays a crucial role in modifying many other parameters of our body. 
This depends on several factors: the country where we live, the ethnicity to which 
we belong to, the historical heritage, tradition and religion, the interaction with 
other people as well as the influence of the climate change on our life. If, on the one 
hand, our genetic heritage makes us unique, we acknowledge that classic genetics 
cannot explain the wide diversity of phenotypes within the population; nor classic 
genetics can explain the different phenotypes and disease susceptibility found in 
identical twins as well as in organisms obtained by cloning technology despite the 
DNA being exactly the same [1]. That means we cannot forget the strong influence 
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of the surrounding environment on our genotype and on our physiological, physical 
and behavioral habits. Such influence, namely, epigenetics, means that the heritable 
changes in gene expression are not due to alteration in the DNA sequence but to 
some modifications occurring upon the DNA without changing the genetic code. 
That said, although we are aware the genetic variability is something peculiar to 
every human being, regardless of the inheritance of favorable or unfavorable genes, 
the transmission to the offspring will be modulated by epigenetics contributing to 
increase further the genetic variation in the population.
2.  Variability among individuals: why it is important to study gene 
polymorphisms
Gene polymorphisms are the most common type of genetic variations in 
humans. They are present in the human population at frequency higher than 1% 
and differ from DNA mutations which are generally observed at extremely low 
frequency and in a restricted number of individuals. While gene polymorphisms 
are not necessarily associated to a specific disease, the gene mutation is generally 
known to cause a genetic disease. In humans the simplest type of polymorphism is 
the single nucleotide polymorphisms (SNPs), representing the most common type 
of nucleotide variation where a single base is substituted by another one (Figure 1). 
A SNP in the coding region of a gene may have four different effects on the result-
ing protein: (1) synonymous substitution, also known as silent mutation, causing no 
amino acid change in the protein, (2) non-synonymous substitution where a nucleo-
tide mutation alters the amino acid sequence of a protein, (3) missense substitution 
consisting of an amino acid change with another and (4) nonsense substitution result-
ing in end of protein translation by a termination codon. About half of all the cod-
ing sequences of SNPs end up in non-synonymous codon changes. However SNPs 
may occur also in the regulatory region of the gene, affecting various properties of 
the protein. These SNPs may influence the protein in terms of quantity and quality, 
activity, processing and trafficking [2]. In the last 20 years, SNPs have raised a lot of 
Figure 1. 
Variation of single nucleotide in the human DNA coding sequence among individuals.
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interest in many scientific fields related to public health and disease. They are also 
investigated in many scientific research areas, ranging from the human ethnicity 
study to the genetics of populations, personalized medicine, pathology, epidemiol-
ogy, pharmacology, immunology and nutrition. More recently they have been con-
sidered relevant also for their role in the exposure science, a novel scientific branch 
linked to toxicology which characterizes and elucidates the contact of humans with 
dangerous chemical, physical and biological agents which represent a potential risk 
for the human health [3]. Actually the environmental exposure, in which also the 
occupational exposure is comprised, is acknowledged to play an important role in 
common chronic diseases, representing a major health concern in the economically 
developed countries. In this context the study of SNPs has a fundamental role to 
detect the human response to toxic and dangerous substances. Although the major-
ity of SNPs of the human genome are of low prevalence [4], including the genes 
implicated in metabolism of environmental chemicals, these may substantially 
contribute to increase the population disease burden [5]. Since the exposure factors 
are numerous and several chronic diseases remain uncertain, it is fundamental to 
study the human genetic variation to understand the exposure-disease associations 
within the global population [6]. On the whole the genetic diversity associated to 
the variability of polymorphisms and to the genetic recombination is a valuable 
resource for humans and other living organisms. The interactions between the 
genetics of human beings and the surrounding environment reciprocally shape one 
with each other in order to reach an equilibrium. However such equilibrium might 
be perturbed by several exogenous factors such as the influence of natural selection, 
the global climate change, the re-emergence of extinct diseases and the admixing 
of different ethnicities due to massive migrations from one country to another. All 
these factors may contribute to change the variation of the gene polymorphism 
pool in the worldwide population. Nowadays the characterization of gene poly-
morphisms of the human population is carried out on individuals belonging to the 
same ethnicity so as to identify ethnic-specific gene/allele frequencies. This strategy 
should help geneticists to identify the genotype frequencies typical of members of 
a community sharing the same language, culture, religion, tradition, nationality, 
ancestry, nutrition, habits and lifestyle which influence the genetic background of 
the group [7]. For this reason the investigational studies of polymorphic genes refer 
more to the concept of ethnicity than to the race. The genetic characterization of 
separate ethnic groups provides useful information to evaluate the difference in the 
susceptibility risk of each cluster. Several papers have been published to report the 
typical genotype frequency of different gene polymorphisms in selected ethnicities 
[8–11]. However, due to the abundance of variation in gene polymorphisms, the 
characterization of the gene pool of a specific group of individuals is incomplete, 
and the genotype frequencies are known only for polymorphisms which have been 
investigated for their role or association to a specific susceptibility or disease. To 
our knowledge the commonest public databases collecting the gene polymorphisms 
available to the scientific community are the following: (1) the single nucleotide 
polymorphism database (dbSNP), a public archive for genetic variation hosted by 
the National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.
nih.gov/snp), and (2) the Ensembl project of genome databases for vertebrates and 
other eukaryotic species (http://grch37.ensembl.org/Homo_sapiens/Variation), 
which is the one we are using in the study of the human SNPs. These two archives 
represent a fundamental resource for our investigational studies on human genetic 
diversity when the laboratory genotyping is not feasible. In this chapter we describe 
some of our studies carried out during the biomonitoring campaigns of exposed 
workers where the biomarkers of dose, effect and susceptibility have been assessed 
in the occupational exposure. In addition we show also a statistical model we 
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previously elaborated to identify ethnic-specific differences in the susceptibility 
risk to the typical exposure found in the workplace. In such model a statistical 
analysis has been done using the publicly available genotype frequency of four 
ethnic groups (Africans, East Asians, South Asians and Europeans) downloaded 
from the Ensembl project of genome databases.
3.  Gene polymorphisms as susceptibility biomarkers in the  
occupational setting
It is widely known the exposure to dangerous substances and carcinogens is com-
monly associated to the individual capability of metabolizing such compounds which 
may vary between different individuals and among ethnicities, each characterized 
by its own specific genetic ancestry. In the occupational setting, the exposure risk is 
traditionally evaluated by the biological monitoring of workers manipulating hazard-
ous agents. Common work-related substances are polycyclic aromatic hydrocarbons 
(PAH), a large class of organic compounds with carcinogenic properties (IARC 
group 1, 2B) used in the manufacture of chemicals, bitumen, and rubber and in shoe 
factories, while in fibreglass industries and in ship constructions, the most common 
dangerous substances are volatile organic compounds (VOCs) such as styrene (IARC 
group 2A), toluene (IARC group 3), xylene (IARC group 3), ethylbenzene (IARC 
group 2B) and benzene (IARC group I). The majority of these hazardous chemicals 
are highly toxic and carcinogenic to humans, and in each company, the officially 
approved occupational exposure limits (OELs) must be respected to ensure a safe 
environment for the workers’ health. The procedure of workplace monitoring is 
generally standardized. It basically consists first of the environmental monitoring 
which measures the workers’ airborne exposure to dangerous compounds and second 
of the biomonitoring which detects metabolites excreted in the biological specimens 
(urine, blood, saliva) and analyses the genotoxicity and gene polymorphisms in the 
subjects [12]. More specifically the biomonitoring allows to detect the following 
specific indicators: (i) the dose biomarkers, i.e. metabolites excreted in urine or in 
other bio-fluids; (ii) the early effect biomarkers, i.e. genotoxicity in peripheral blood 
lymphocytes and/or in buccal exfoliated cells; and (iii) the susceptibility biomarkers, 
i.e. the gene polymorphisms encoding for biotransformation enzymes during the 
exposure. This practice is carried out on exposed workers and nonexposed controls 
with the goal to assess the presence and quantify the potential health risks. While 
the dose biomarkers and the genotoxic damage may be immediately analyzed and 
quantified, the susceptibility biomarkers, being a qualitative parameter, are not 
quantifiable in terms of single polymorphism belonging to a subject. In such case 
the results obtained by the genetic analysis on groups of exposed workers have to be 
considered all together to quantify the relative susceptibility risk with respect to a 
control group. Based on our experience, the polymorphic genes of the worker popula-
tion are identified following extraction of the genomic DNA of the subject to identify 
the genotype encoding the enzyme involved in the detoxification process. Once the 
worker genotype has been identified, it gives an important indication of the specific 
susceptibility to that substance by associating the genetic information with the dose 
and/or the early effect biomarker. In general the homozygous variant genotype 
(minor allele) is considered a risk allele with respect to the homozygous wild-type 
genotype (major allele) although there might be a few exceptions [13]. The workers 
exposed to potential hazardous substances are enrolled in the biomonitoring study 
only on a voluntary basis to allow the occupational health risk assessment. The results 
of the gene polymorphism assay together with the data gained by environmental and 
personal biomonitoring are analysed at the epidemiological level (1) to quantify the 
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indoor exposure and the individual absorbed dose according to the company OELs 
for the specific hazardous agent, (2) to assess the potential genotoxic effect and (3) to 
evaluate the influence of the investigated polymorphic genes on the toxicant absorbed 
dose. Although workers make use of personal protection equipment (PPE), it is 
possible, in some cases, the high volatility of organic compounds might spread indoor, 
increasing the toxic substance threshold within the work environment. The finding of 
an association between the exposure to specific dangerous substances, the presence of 
cell genotoxicity and the variable functionality of gene polymorphisms are useful to 
identify specific or common susceptibilities in the exposed groups.
3.1 Identification of gene polymorphisms relevant to the occupational exposure
In our experience several biomonitoring studies have been promoted and carried 
out in industrial companies to assess the exposure risk of workers manipulating toxic 
and carcinogenic agents. Here we report the most recent results obtained during 
four different campaigns carried out in the last 6 years. In 2012, our research group 
analyzed the exposure of 315 workers to benzene in a petrochemical plant in Italy 
to evaluate the dose biomarkers S-phenylmercapturic acid (SPMA) and trans,trans-
muconic acid (t,t-MA) in the worker urine samples and the susceptibility biomarkers 
in the blood specimens [14]. Since the GST enzymes may influence the metabolite 
excretion, the research project analyzed the association between metabolite excre-
tion and contribution of the glutathione S transferase T1 (GST-T1) and M1 (GST-M1) 
polymorphisms to the detoxification. The results confirmed the modulating effect on 
the excretion of SPMA metabolite in urine by the genetic polymorphism of GST-T1 
after exposure to low benzene doses. The same modulating effect was caused by the 
GST-M1 polymorphism but only at higher benzene doses, like those produced by cig-
arette smoking. The genotype of the 315 workers has been characterized to identify 
groups with the highest susceptibility; the workers’ gene frequency of GST-T1 posi-
tive/null genotype was 0.78 vs. 0.22, while the frequency of GST-M1 positive/null 
was 0.47 vs. 0.53. Taking into account the genotype frequency of both enzymes, it 
looks that the GST-M1 polymorphism positive/null is less efficient in the detoxifica-
tion process than GST-T1. A second study on benzene exposure has been carried out 
on 301 employees in the oil refinery. The effect of polymorphic genes GST-T1, GST-
M1, glutathione S transferase A1 (GST-A1), epoxide hydrolase 1 (EHPX1), NAD(P)
H quinone dehydrogenase 1 (NQO1), cytochrome P450 2E1 (CYP2E1), cytochrome 
P450 1A1 (CYP1A1*2A) and myeloperoxidase (MPO) involved in the detoxification 
of benzene has been analyzed. Here the dose biomarker was worked out as the ratio 
(R) between t,t-MA and S-PMA metabolites excreted in the urinary samples. The 
effect of smoking as confounding factor contributed to increase the relative produc-
tion of S-PMA with respect to t,t-MA reducing the R value. This result was attributed 
to the higher levels of glutathione (GSH) in the red blood cells of smokers than in 
non-smokers. The analysis of susceptibility biomarkers showed a strong influence 
of GST-T1 positive polymorphism on the excretion of urinary S-PMA, reducing the 
conjugation rate of benzene epoxide with GSH in the GST-T1 null subjects. To a lesser 
extent, a similar effect was observed in individuals with GST-M1 null, GST-A1 and 
NQO1 mutant genotypes. It has been observed that in subjects with the double null 
GST-T1 and GST-M1 genotypes, an amplification of the t,t-MA biochemical pathway 
occurred with respect to the SPMA pathway [15]. However the activity of one GST 
is compensated by another in GST-M1 and GST-A1 defective subjects, but not in 
GST-T1 null genotypes, whose S-PMA average excretion is about 50% with respect to 
the positive genotypes for the same benzene exposure [16]. A further biomonitoring 
campaign has been conducted in two different manufacturing sites of central Italy 
on 30 styrene-exposed workers and 26 unexposed controls. In this work the authors 
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investigated the effects of polymorphic genes CYP2E1, EPHX1, GST-T1 and GST-M1 
on the urinary concentrations of the styrene metabolites, i.e. mandelic acid (MA) 
and phenylglyoxylic acid (PGA), and on the ratio between MA and PGA. Here the 
concentrations of urinary styrene and of airborne styrene have been determined. In 
the exposed workers, a lower excretion of PGA and MA metabolites was detected 
in subjects with cytochrome P450 2E1*5B (CYP2E1*5B) and cytochrome P450 2E1*6 
(CYP2E1*6) heterozygous genotype with respect to the homozygous wild type indi-
cating the influence of SNPs on the dose biomarkers. Furthermore a reduced value 
of metabolite ratio (MA + PGA/urinary styrene) was observed in exposed work-
ers with the EPHX1 Tyr113His slow/mutant allele in comparison to those with the 
wild-type allele. The results indicate a reduced excretion of MA + PGA, evidenced 
also by other authors only in association with other genotypes. This study confirmed 
the variability in the excretion of urinary styrene metabolites, strictly related to the 
individual gene polymorphisms, can significantly impact on the biological monitor-
ing of styrene exposure. In the CYP2E1*5B and CYP2E1*6 heterozygous genotypes as 
well as in the EPHX1 slow mutant genotypes, the average excretion of MA + PGA is, 
respectively, reduced 20 and 35% in comparison to the wild-type population [17].
3.2  Operative procedure and ethical use of workers’ biosamples for  
occupational risk assessment
The availability of human biological samples is fundamental for the biomonitor-
ing since it allows to estimate the exposure risk of the workers. The mostly used 
biosamples are whole blood with its separated fractions (plasma, serum, buffy 
coat, peripheral mononuclear cells, blood clot), urine, saliva, oral cell mucosa and 
cell components such as DNA and mRNA. In the occupational studies, biosamples 
are kindly donated from the workers agreeing to the biomonitoring project, pro-
vided that they give the informed consent. In Italy the biomonitoring procedure is 
sub-conditioned to the availability of the host manufacture company to agree the 
investigational study. The final purpose of the research has to be approved by the 
local health unit, by the research institute and, only in case of experimental clinical 
protocols, by the ethical committee. As volunteers the workers might join but not 
necessarily have to participate to the study related to the occupational health risk 
exposure, and they are not forced to undergo genetic screening. Workers participat-
ing to the programme agree by informed consent and are invited to fill a question-
naire to exclude all the potential confounding factors interfering with the analysis 
(drug assumption, alcohol consumption, smoking habit, chronic or acute diseases) 
before donating their biological samples. Those wishing to support the observational 
study are aware their specimens will be used only for the scientific purpose and will 
be collected, stored and used according to the ethical guidance of the Declaration 
of Helsinki [18]. The collection, storage and processing of the biosamples must be 
performed under strictly controlled procedures, in order to preserve their integrity 
and quality. In particular, the storage of genetic data collected in the workplace is 
fundamental since they contain sensitive health and non-health-related informa-
tion about individuals which must be adequately protected in research as well as in 
clinical studies. This principle has been formalized in Europe on 27 April 2016 with 
the new General Data Protection Regulation (EU GDPR 2016/679), effective from 25 
May 2018, which has entered into force and repealed the previous Directive 95/46/
EC for personal data protection. The aim of the regulation is to promote and harmo-
nize the personal data protection in the EU [19]. In the occupational setting, three 
types of biosamples are mainly requested to the workers, i.e. whole blood, urine 
and buccal cells. To perform genetic analysis on the biospecimen, the workers who 
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agree to donate the sample must be informed of the purpose of the research project 
in all the aspects; they also should understand the utility, the scope and the limit of 
the analysis. Workers and their supervisors or representatives are informed on the 
modality, procedure and scheduling related to the donation of the biosamples. For 
instance, in the case of urine and buccal cells, workers can themselves self-collect 
their specimens provided that they are informed in advance on the day of collec-
tion. The collaborating institute ensures analysis of all the data, and for the genetic 
results, it ensures anonymity and confidentiality, un-disclosure in public databases, 
exclusivity and availability to medical staff of the company if required for internal 
use. Most importantly the genetic data are analysed as groups and not individually 
in order to avoid any misinterpretation or discrimination. As stated before, the 
information on the susceptibility risk is not relevant at the individual level, while it 
becomes significant once a large number of subjects belonging to the same ethnicity 
are available. The genetic analysis should be scientifically validated and must not 
involve any kind of discrimination for the individual.
3.3 Our method for gene polymorphism analysis
The workers’ blood samples are harvested in tubes containing either heparin 
or K2-EDTA from the medical staff of the company following workers’ informed 
consent and according to the ethical guidelines of our research institute. All proce-
dures performed in this study involving human participants [18] are in accordance 
with the ethical standards of our institutional committee and with the local health 
unit. Urine samples may be immediately frozen at −20°C after harvesting, and 
saliva and buccal cells may be stored at RT, while the blood samples may be stored 
up to 24 hours at a temperature between 4 and 10°C or immediately frozen for the 
genetic analysis. Blood genomic DNA is isolated by using a DNA blood kit, checked 
for the quality by agarose gel electrophoresis, quantified by a nanophotometer and 
stored at 4°C or −20°C. Although there are many novel and reliable techniques 
used to assess the gene polymorphisms such as Taqman assay, amplification refrac-
tory mutation system mass spectrometry (PCR-ARMS), confronting two-primer 
pair (CTPP-PCR), high-resolution melting and different types of mini-sequencing, 
our choice is oriented towards the traditional method based on polymerase 
chain reaction (PCR) followed by restriction fragment length polymorphism 
(RFLP) (Figure 2). We have tried also the fast and less expensive CTPP-PCR 
protocol developed previously in which the resulting genotype is obtained by 
a traditional PCR carried out with two couples of primers, avoiding to proceed 
for the enzymatic digestion [11]. However in our hands such protocol turned out 
Figure 2. 
Methodological procedure for gene polymorphism analysis by PCR-RFLP.
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to be unreliable. In particular we applied this alternative method to detect two 
polymorphisms of one gene involved in response to oxidative stress and ototoxic-
ity (NRF2 -617C/A and -653A/G), but the data were not completely satisfactory 
since CTPP-PCR produced contradictory results, particularly for the heterozygosis 
classification, requiring another orthogonal technique for confirming the data 
[20]. In the following section, we propose a list of the gene polymorphisms that we 
usually evaluate in the biological monitoring of the occupational exposure. They 
have been grouped on the basis of the enzyme function, i.e. detoxification, oxida-
tive stress and DNA repair. The majority of them has been analyzed and reported 
in our previous published papers as biomarkers of susceptibility to the exposure of 
several organic compounds including styrene, toluene, ethylbenzene, benzene as 
well as biomarkers of genotoxic damage and of oxidative stress [14–17, 21]. Table 1 
shows a list of the analyzed susceptibility biomarkers together with the PCR-RFLP 
protocols which have been used by our group with some modifications.
3.4  Use of an alternative method to detect human gene polymorphisms  
without genotyping
In the context of occupational and environmental exposure, the role of bio-
transformation enzymes is to ensure efficient detoxification of endogenous and 
exogenous compounds by specific biochemical pathways. These modify the danger-
ous substances into inactive compounds which once excreted into urine will avoid 
metabolite accumulation and harm the human organism. Although the screening 
of individual gene polymorphisms by the molecular biology laboratory is the ideal 
procedure to assess the susceptibility of each individual participating to the study, 
the availability of workers to donate the biosample is fundamental to proceed with 
the genetic analysis. One difficulty may be represented by the lack of workers’ 
consent to venipuncture or in general to the biosample harvesting, either because 
they are simply not used to this procedure or because the venipuncture is perceived 
as too invasive and painful technique or due to the worker fear and insecurity of 
the potential analysis result. However the gene polymorphism assessment has 
no diagnostic value in terms of predisposition to develop a particular disease. In 
our experience we noted that workers of mixed ethnicities are employed in many 
industrial companies, and in this context, it might be difficult, if not impossible, to 
collect particularly the blood samples in comparison to urine. This may depend on 
several factors: the poor knowledge of the language, the difficulty of communica-
tion and the difference in culture, habit, diet and belief among workers. To bypass 
such critical issue and achieve the ethnic-specific genotype information without 
making use of the laboratory analysis, we took advantage of a public and online 
available database (http://grch37.ensembl.org/Homo_sapiens/Variation) containing 
a provisional collection of the majority of genotype and allele frequencies of several 
ethnic groups. This resource is freely accessible and allowed us to obtain the genetic 
profile of different ethnicities which helped to predict and identify in silico specific 
susceptibilities within the population. This model, based on the statistical method 
of principal component analysis (PCA), has been designed to assess the relative risk 
of the homozygous variant and heterozygous genotype in four macro-groups, i.e. 
Africans, Eastern Asians, South Asians and Europeans, with respect to the world-
wide population [34]. It has been conceived to identify the critical susceptibilities 
in the polymorphisms of genes involved in three main functional biochemical 
pathways, i.e. detoxification, oxidative stress and repair of damaged DNA, fol-
lowing exposure to the hazardous compounds. The SNPs have been selected on 
the basis of the exposure to toxic and carcinogenic substances commonly found 
in manufacturing factories and shipyards. Below we list the gene polymorphisms 
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SNPs rs number Primer sequences Annealing 
temperature (°C)
Restriction 
enzyme
Restriction pattern (bp) References
Detoxification
GST-T1 17856199 F: 5′ -TTC CTT ACT GGT CCT CAC ATC TC-3′
R: 5′ -TCA CCG GAT CAT GGC CAG CA-3′
62 None None Teixeira et al. [22]
GST-M1 366631 F: 5′-GAA CTC CCT GAA AAG CTA AAG C-3′
R: 5′-GTT GGG CTC AAA TAT ACG GTG G-3′
62 None None
GST-P1 1695 F: 5′-ACC CCA GGG CTC TAT GGG AA-3′
R: 5′-TGA GGG CAC AAG AAG CCC CT-3′
62 BsmAI Wt: 176
Het: 176, 91, 85
Mut: 91, 85
GST-A1 3957357 F: 5′-GCA TCA GCT TGC CCT TCA-3′
R: 5′-AAA CGC TGT CAC CGT CCTG-3′
64 EarI Wt: 400
Het: 400, 308, 92
Mut: 308, 92
Ping et al. [23]
CYP1A1*2A 4646903 F: 5′-CAGTGAAGAGGTGTAGCCGCT3′
R: 5′-TAGGAGTCTTGTCTCATGCCT3′
65 MspI Wt: 340
Het: 340, 200, 140
Mut: 200, 140
Nie et al. [24]
CYP2E1*5B 3813867 F: 5′-CCA GTC GAG TCT ACA TTG TCA-3′
R: 5′-TTC ATT CTG TCT TCT AAC TGG-3′
55 RsaI Wt: 360, 50
Het: 410, 360, 50
Mut: 410
Le Marchand et al. 
[25]
CYP2E1*intron6 6413432 F: 5′-TCG TCA GTT CCT GAA AGC AGG-3′
R: 5′-GAG CTC TGA TGC AAG TAT CGC A-3′
62 DraI Wt: 572, 302, 121
Het: 874, 572, 302, 121,
Mut: 874, 121
Liu et al. [26]
EPHX1 Ex_3 1051740 F: 5′-GAT CGA TAA GTT CCG TTT CAC C-3′
R: 5′-ATC CTT AGT CTT GAA GTG AGG AT-3′
52.6 EcoRV Wt: 160
Het: 160, 140, 20
Mut: 140, 20
Erkisi et al. [27]
EPHX1 Ex_4 2234922 F: 5′-GGG GTA CCA GAG CCT GAC CGT-3′
R: 5′-AAC ACC GGG CCC ACC CTT GGC-3′
58 RsaI Wt: 295, 62
Het: 295, 174, 62
Mut: 174, 121, 62
Hassett et al. [28]
MPO 2333227 F: 5′-CGG TAT AGG CAC ACA ATG GTG AG-3′
R: 5′-GCA ATG GTT CAA GCG ATT CTT C 3’
56 AciI Wt: 168, 121, 61
Het: 289, 168, 121, 61
Mut: 289, 61
Cascorbi et al. [29]
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SNPs rs number Primer sequences Annealing 
temperature (°C)
Restriction 
enzyme
Restriction pattern (bp) References
Oxidative stress
NRF2 – 617C/A 6721961 F1 5′- CCC TGA TTT GGA GTT GCA GAA CC-3′
R2 5′- CTC CGT TTG CCT TTG ACG AC-3′
62 NgoMIV Wt: 191, 91
Het: 281, 191, 91
Mut: 282
Chiarella et al. [20]
NRF2 – 653A/G 35652124 F1 5′-CTT TTA TCT CAC TTT ACC GCC CGA G-3’ R2 5’-GGG 
GTT CCC GTT TTT CTC CC-3′
62 BseRI Wt: 180, 138
Het: 318, 280,180,
Mut: 318
NQO1 1800566 F: 5′-TCC TCA GAG TGG CAT TCT GC-3′
R: 5′-TCT CCT CAT CCT GTA CCT CT-3′
65 HinfI Wt: 195
Het: 195, 151,
Mut: 151
Chen et al. [30]
HO-1 2071746 5′-GTT CCT GAT GTT GCC CAC CAA GC-3′
5′-CTG CAG GCT CTG GGT GTG ATT TTG-3′
60 HindIII Wt: 131
Het: 20, 131
Mut: 20
Song et al. [31]
DNA repair
XRCC1 399 G/A 25487 F: 5′-TTG TGC TTT CTC TGT GTC CA-3′
R: 5′-TCC TCC AGC CTT TTC TGA TA-3′
61 MspI Wt: 374, 221
Het: 615, 374, 221
Mut: 615
Kowalski et al. [32]
XRCC1 194 1799782 F: 5′-GCC CCG TCC CAG GTA-3′
R: 5’-AGC CCC AAG ACC CTT TCA TC-3’
61 MspI Wt: 292, 174
Het: 313, 292, 174
Mut: 313, 174
hOGG1 326 1,052,133 F: 5′-GGA AGG TGC TTG GGG AAT-3′
R: 5′-ACT GTC ACT AGT CTC ACC AG-3’
58 Fnu4HI Wt: 200
Het: 200, 100
Mut: 100
Le Marchand et al. 
[33]
Wt, Homozygous wild type; Het, heterozygous; Mut, homozygous mutant.
Table 1. 
List of susceptibility biomarkers analysed in our biomonitoring campaigns.
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reported in Table 1 and commonly assessed in the laboratory genotyping during 
the biomonitoring campaigns that in our predictive model we integrated with other 
relevant polymorphic genes [34].
1. Detoxification pathway genes: Glutathione S transferase (GST-A1) rs3957357, 
(GST-M1) rs366631, (GST-T1) rs17856199, (GST-P1) rs1695, epoxide hydrolase 
1 (EPHX1 Ex_3) rs1051740, (EPHX1 Ex_4) rs2234922, cytochrome P450 1A1 
(CYP1A1_2A) rs4646903, cytochrome P450 2E1 (CYP2E1*6) rs6413432, 
(CYP2E1*5B) rs3813867, myeloperoxidase (MPO) rs2333227.
2. Oxidative stress genes: Nuclear factor (erythroid-derived 2)-like 2 (NRF2) 
rs6721961, NRF2 rs35652124, heme oxygenase (HO-1) rs2071746, NAD(P)H 
quinone dehydrogenase 1 (NQO1) rs1800566.
3. DNA repair pathway genes: X-ray repair cross-complementing 1 (XRCC1) 
rs25487, X-ray repair cross-complementing 3 (XRCC3) rs1799782, 8-oxogua-
nine glycosylase (hOGG1) rs1052133.
The model provides the relative risk (RR) for each ethnic group. RR has been 
calculated as the ratio between the variations of the gene frequency of the specific 
ethnic group with respect to the variation of the gene frequency of the worldwide 
population. If the variation of the gene frequency is >1, it means the susceptibility 
risk is higher in the ethnic group than in the general population. The most disadvan-
tageous condition, unless specified, is generally associated with the frequency of the 
homozygous variant, namely, the mutant genotype, although in very few excep-
tions it might associate to the homozygous wild-type genotype. The details of the 
rationale, method and elaboration of the susceptibility relative risk of the model are 
available in our previous paper [34]. Briefly, the predictive model allows to identify 
(1) ethnicity similarity in the susceptibility risk, (2) correlation of the ethnicity with 
specific metabolic genes and (3) estimation of the RR indicator in the four ethnic 
macro-populations. In Figure 3 we report a quantification of the RR for all the four 
ethnic groups which has been worked out for the three gene polymorphism clusters 
(i.e. detoxification, oxidative stress and DNA repair). As seen in the graph, the 
Figure 3. 
Calculation of the indicator risk in the four ethnic populations.
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minimum risk for the three categories of gene polymorphisms is observed in the case 
of Africans, while South Asians are associated to the highest risk for detoxification 
and oxidative stress; Europeans show the highest risk in the DNA repair; and East 
Asians show a high risk in the oxidative stress. According to the following results, it 
seems that South Asians are associated with a cumulative highest susceptibility risk 
in comparison to the other populations, while Africans are associated to the lowest 
risk. The model cited here may represent a useful tool to predict the susceptibility 
risk associated to the occupational exposure and a potential alternative substitut-
ing the genotype screening of workers. However, it is still provisional, and it could 
be improved considering other ethnicities and including in the analysis a higher 
number of polymorphic genes involved in the biotransformation of the toxic and 
carcinogenic substances found in the workplace.
4. Conclusions
The recent and massive migration of populations of various ethnicities in the 
European countries and the global climate changes not only are affecting the human 
social life and behaviors but represent also a serious health and safety concern for 
the population. Any individual response to the environmental and occupational 
exposure is dependent on different factors; one of the most important and obvious 
is related to the personal genetic background characterizing different population 
groups. However many other exogenous factors such as the individual lifestyle, 
the smoking habit, the use of drugs, the type of diet and the ubiquitous presence 
of toxicants are factors affecting the individual genetic heritage. A novel and 
effective approach to the management of the public health risk is urgently needed. 
Although the genetic information is correctly used in the occupational risk assess-
ment models, various ethical and social issues may arise when dealing with gene 
polymorphisms at workplace, particularly when the labour force is heterogeneous. 
The possible reluctance of immigrants and of local workers to give the consent to 
the biosample donation, the expenses sustained by the laboratory for the analysis 
as well as the necessity of approvals by the health unit and the manufacturing 
company to allow the investigational study do not facilitate the success of the 
biomonitoring campaign which, if not mandatory as the health surveillance, is still 
important to assess and quantify the exposure to hazardous substances and the 
susceptibility risk at workplace. Nonetheless the worker misinterpretation or the 
miscommunication of genetic susceptibility and vulnerability concepts might be 
misunderstood and considered as personal weakness or inability to perform a spe-
cific job task. This erroneous interpretation of susceptibility should be transferred 
to the workers in a clear and correct form so as they know the individual variability, 
regardless of the difference in genetic heritage, is not a negative aspect but should 
be conceived as a personal trait. The role of genotyping in the occupational expo-
sure, no matter if it is carried out in a laboratory or by a statistical analysis, is to 
define a susceptibility risk for the investigated ethnic group. This information will 
be useful to take into account the difference between ethnicities so as to verify the 
company OELs are safe or need to be adjusted taking into account different suscep-
tibilities. In the absence of blood sample or consent from the worker to donation, 
the availability of a statistical predictive model, based on the genotype publicly 
available on web databases, should be necessarily regarded as useful indicator of the 
probable subject’s genotype of the ethnic group to which the individual belongs to. 
Even though the access to genotyping is not possible, a certain number of advan-
tages might be achieved: reduction of the laboratory costs for the research institute, 
no need of informed consent from workers and no need of trained staff and 
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laboratory equipment for blood collection and therefore no venipuncture, which 
means no harm to the worker. The predictive model mentioned here may represent 
a potential but also amendable alternative to the laboratory genotyping of work-
ers and might involve the study of other ethnic groups. However keeping updated 
these databases will be useful not only to better characterize all the ethnic groups’ 
genotypes but also to manage the novel susceptibility risks that might compromise 
the individual health protection and safety in the workplace [35].
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